ANI Pharmaceuticals
ANIP
#5253
Rank
C$2.24 B
Marketcap
C$98.96
Share price
-0.07%
Change (1 day)
-12.27%
Change (1 year)

EPS for ANI Pharmaceuticals (ANIP)

EPS in 2026 (TTM): C$7.26

According to ANI Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$7.42. In 2025 the company made an earnings per share (EPS) of C$5.01 an increase over its 2024 EPS that were of C-$1.60.

EPS history for ANI Pharmaceuticals from 2013 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$7.2644.81%
2025C$5.01-412.5%
2024C-$1.60
2022C-$4.35-6.46%
2021C-$4.6672.87%
2020C-$2.69-476%
2019C$0.72-62.12%
2018C$1.89
2015C$1.92-47.66%
2014C$3.67-142.11%
2013C-$8.71

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novartis
NVS
C$7.52 1.35%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
C$1.02-86.29%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
C$11.12 49.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Jazz Pharmaceuticals
JAZZ
C$5.20-29.92%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Evoke Pharma
EVOK
C-$3.61-148.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
C-$6.23-183.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$0.64-91.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Royalty Pharma
RPRX
C$2.19-70.48%๐Ÿ‡ฌ๐Ÿ‡ง UK
Lannett Company
LCI
C-$36.21-588.03%๐Ÿ‡บ๐Ÿ‡ธ USA